Oesophagitis and the role of antacid therapy.
D000464:Alginates / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000494:pharmacology / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D017640:Silicates; D012824:Silicic Acid / Q000627:therapeutic use; D017693:Sodium Bicarbonate
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D004338:Drug Combinations; D017640:Silicates; D012824:Silicic Acid; D000536:Aluminum Hydroxide; C007829:alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination; C021080:pyrogastrone; D002927:Cimetidine; D017693:Sodium Bicarbonate; D008787:Metoclopramide; D002229:Carbenoxolone